Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron

Pediatric kidney transplantation in Europe, a clinical snapshot pilot () Oomen L, Bootsma-Robroeks CM, Bouts AH, Carbonell Pradas M, Gander R, Kienzl-Wagner K, König P, et al. Journal article Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework () Della-Torre E, Talarico R, Ballarin J, Bozzalla-Cassione E, Cardamone C, Cigolini C, Ferro F, et al. Journal article, Review article Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique (2025) Rizzo C, Coronel L, De Lorenzis E, Rubortone P, Möller I, Miguel Perez M, Tur C, et al. Journal article A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research. (2025) Amaral T, Nanz L, Higuita LMS, Ascierto P, Berking C, Couselo EM, Donia M, et al. Journal article Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial (2025) Powles T, Tagawa S, Vulsteke C, Gross-Goupil M, Park SH, Necchi A, De Santis M, et al. Journal article Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma (2025) Muñoz Couselo E, Berking C, Baurain JF, Martelli S, Arntz R, Savoia P Journal article Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome (2024) Rots D, Bouman A, Yamada A, Levy M, Dingemans AJ, de Vries BB, Ruiterkamp-Versteeg M, et al. Journal article Correction: Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals (European Journal of Human Genetics, (2024), 32, 8, (928-937), 10.1038/s41431-024-01610-1) (2024) Layo-Carris DE, Lubin EE, Sangree AK, Clark KJ, Durham EL, Gonzalez EM, Smith S, et al. Journal article, Erratum 177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study (2024) Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel ME, Kunz PL, Chasen B, et al. Journal article Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage (2024) Connolly SJ, Sharma M, Cohen AT, Demchuk AM, Członkowska A, Lindgren AG, Molina CA, et al. Journal article